San Francisco, CA (December 13, 2017) -- CB Insights today announced that NemaMetrix Inc. is the winner of the first "Most Innovative" health startup at Demo Day.
While more than 2,000 companies applied for the opportunity to pitch at Demo Day, NemaMetrix was one of 40 companies chosen to present at the A-ha! Conference. CB Insights selected NemaMetrix as part of an elite group of startups driving progress in artificial intelligence, fintech, health and bleeding-edge technologies.
Presenting companies were selected based on two rounds of interviews and questions posed by CB Insights researchers about the company’s market traction, product availability, originality, founder expertise, revenue, and funding.
Competing at the event, the CEO of NemaMetrix, Matt Beaudet said, “We are honored to have been chosen for the first CB Insights Demo Day and are incredibly proud to share our success story with this broad and experienced audience."
Interesting facts about Demo Day presenters:
- All companies are Series A or earlier stage
- 8 countries are represented
- VC backers for these companies include Sequoia Capital, Khosla Ventures, and 500 Startups, among others.
- Angel investors for Demo Day companies include Will.I.Am, Ben Roethlisberger, and Steve Case.
The Demo Day Companies (by category):
|JASK||Bounce Imaging||Cape Analytics||Bwom|
|ManoMotion||CannaKorp, Inc.||CNote||ContinUse Biometrics Ltd.|
|PerceptIn||Electronic Gaming Federation||CrowdStreet||Dermasensor|
|RealWear||Geltor, Inc.||Kin Insurance||NemaMetrix Inc.|
|Sherpa||OndaVia, Inc||Rentalutions||Trayt Inc|
|Waygum, Inc.||PlanIT Impact||Starling||UnaliWear|
|When Labs||Trillium Secure||Vymo Solutions||yband therapy AG|
About NemaMetrix Inc.
NemaMetrix mission is to enable scientists and researchers around the world to better understand human health and explore potential treatments for high-impact disorders such as Alzheimer’s disease, epilepsy and cancer by offering a more affordable and accessible platform.
The company develops solutions and commercializes proprietary systems for the genetic modification of simple microscopic living animals to act as human proxies for disease research and drug discovery and help our customers reveal new insights into the true nature of genetic mutations.
Wenlan Hu, Director of Marketing and Sales, 541-206-8430, [email protected].
About CB Insights
Our team builds technology that helps corporations guess less and win more. We aggregate and analyze terabytes of data and use machine learning, algorithms and data visualization to help corporations replace the three Gs (Google searches, gut instinct and guys with MBAs) so they can answer massive strategic questions using probability not punditry.
Farrah Kim, Senior Public Relations & Communications Manager, 212-292-3148, [email protected]
To learn more about A-ha!, visit: http://events.cbinsights.com/aha